Navigation Links
Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc.
Date:7/29/2009

ng reputation for consistent delivery of high quality experimental data in support of Merck's external collaborations and internal research projects," said Dr. Rupert Vessey, Vice President, Merck Research Laboratories. "This agreement assures continued access to these services for our researchers while securing a future for the facility as an integral part of a world leading drug development service provider."

About Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in 25 countries, and more than 10,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release, which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, the closing of the announced transaction, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or
'/>"/>

SOURCE Covance
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Covance Reports Second Quarter Revenue of $466M and EPS of $0.66
2. Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2009 Financial Results Conference Call
3. Covance Expands Analytical and Stability Service Capacity in North America
4. Covance to Present at Goldman Sachs Thirtieth Annual Global Healthcare Conference
5. Covance to Present at William Blair & Companys 29th Annual Growth Stock Conference
6. Covance Announces Monte Jarvis as Vice President of Global Data Management and Biostatistics for Periapproval Services
7. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
8. Covance to Present at the Deutsche Bank 34th Annual Health Care Conference
9. Covance To Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
10. Covance To Present at Bairds 2009 Growth Stock Conference
11. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... Orlando, FL (PRWEB) December 26, 2014 ... visitor health insurance in the USA, announced today a ... to assist members in choosing the right plan for ... take the complexity out of the selection process when ... premiums by age group with only a few clicks. ...
(Date:12/25/2014)... The microscopy market is estimated to ... $5,756.0 million by 2019. Optical microscopy is the ... microscopes product segment is expected to show the ... focus on nanotechnology, technological advancements, and increasing federal ... , Get Full Copy of Report @ ...
(Date:12/25/2014)... 26, 2014 The report “TS-1 (Colorectal ... on the current treatment landscape, unmet needs, current pipeline ... is an anti-cancer drug which is typically used for ... also used for treating gastric cancer and pancreatic cancer. ... The drug was first approved in 1999 in Japan ...
(Date:12/25/2014)... Dylan Queen, a famous online company supplying women’s special ... prom dresses, most of which are priced under $200. ... the promotion is valid until Jan. 22, 2015; the ... market. , The prom dresses in this new collection ... strapless, empire strapless chiffon, one shoulder, floor-length, V-neck beading, ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
... technique could speed the diagnosis, French researchers say ... radiologists report they,ve simplified a method of scanning ... making it easier to diagnose the mind-robbing condition. ... routinely using the approach, but early tests are ...
... DIEGO, June 24 Behavioral Risk Management is ... the strong message from,a survey conducted by the ... and effectiveness in Behavioral Risk,Management., Additionally, survey ... beyond an emerging focus area to one that ...
... Abusing Prescription Medications Get ... or Friend, NEW YORK, June 24 A house ... secure, yet it is here that teens are,prone to get ... drug misuse and abuse, the Partnership for a Drug-Free,America(R) and ...
... announced the launch of the 3M™ Filtron™ 1900 tie-on ... seeking a premium surgical mask. The new 3M ... a rayon outerlayer to deliver increased breathability and comfort, ... a popular "duckbill" design, the 3M Filtron 1900 surgical ...
... Year Revenue Guidance to a range of $395 Million to $405 ... ... Revenue of $101.9 million, up 57.4% over first quarter 2007 - Gross ... income of $9.6 million, up 135.4% over first quarter 2007, WARSAW, Ind., June ...
... Way to Fight Common Illnesses, HOLLYWOOD, Calif., June ... site, http://www.help2getbetter.com, and the sale,of online sick ... fight common illnesses. What makes these sick packs unique ... but come packaged,together conveniently in one- or two-dose portion ...
Cached Medicine News:Health News:Brain Scans Detect Alzheimer's Disease Quickly 2Health News:Brain Scans Detect Alzheimer's Disease Quickly 3Health News:Behavioral Risk in the Workplace: Behavioral Risk Management Continues to be an Important Best Practice Area for Employers 2Health News:Abbott and Partnership for a Drug-Free America Launch 'Not In My House' to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse 2Health News:Abbott and Partnership for a Drug-Free America Launch 'Not In My House' to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse 3Health News:3M Health Care launches new high-performance surgical mask 2Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 2Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 3Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 4Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 5Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 6Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 7Health News:Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million 8Health News:Launch of help2getbetter.com Provides Convenience and Portability to Household Medicines 2
(Date:12/22/2014)... NxStage Medical, Inc. (NASDAQ: NXTM ... announced today that the U.S. Food and Drug ... perform hemodialysis overnight while the patient is at ... System One is the first and only hemodialysis ... Home nocturnal hemodialysis is an ...
(Date:12/22/2014)... 22, 2014 Research and Markets ... the "Investment Analysis of the US Medical ... http://photos.prnewswire.com/prnh/20130307/600769 ... medical device sector identifies the key trends and ... investments, and mergers and acquisitions. The ...
(Date:12/22/2014)... Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... issued the following open letter to shareholders from ... Med. Sc. Dear RXi Shareholders, ... of inaccurate statements posted on certain social media ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... Raylene Riha and her husband, Michael, filed suit today ... seeking compensation for injuries caused by failures of Raylene,s ... been recalled.  John David Hart of the Law Offices ... the attorney representing Raylene and Michael Riha in the ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ...  and Watson Laboratories, Inc. -- Florida, (collectively "Watson") ... U.S. Food and Drug Administration (FDA) seeking approval ... 10,15, 20, 30, 40, 60 and 80 mg ...
Cached Medicine Technology:Law Offices of John David Hart: DePuy Recalled Hip Device Lawsuit Filed by Houston Woman 2Watson Confirms OxyContin® Patent Challenge 2Watson Confirms OxyContin® Patent Challenge 3
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Digitoxin in human serum....
For the quantitative in vitro determination of Phenytoin in human serum....
For the quantitative in vitro determination of Phenobarbital in human serum....
Medicine Products: